United States · 
Who invested in Immunai?
Immunai's investors include 8VC, Alexandria Venture Investments, Catalio Capital Management and TLV Partners.
United States · Series B startup
Who invested in Immunai
Funding summaryUpdated 26 Oct 2026
$215Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $215MOct 2021
- Investors
- 4
The rounds
- Oct 2021
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
TLV Partnersno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Immunai as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Immunai
How much has Immunai raised?
Immunai has raised $215M across 1 round since 2021.
When did Immunai last raise?
Immunai's most recent round was a Series B of $215M in Oct 2021.
What was Immunai's biggest round?
Its most recent round, $215M in Oct 2021, is also its largest on record.
Who backed Immunai first?
Immunai's first round on record, in Oct 2021, was backed by 8VC, Alexandria Venture Investments and Catalio Capital Management and 1 others.
What stage is Immunai at?
Immunai's latest named round is a Series B, in Oct 2021.
Where is Immunai based?
Immunai is based in the United States.
Companies like Immunai
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.